These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6815409)

  • 1. Chagas' disease: selective affinity and cytotoxicity of Trypanosoma cruzi-immune lymphocytes to parasympathetic ganglion cells.
    Teixeira ML; Rezende Filho J; Figueredo F; Teixeira AR
    Mem Inst Oswaldo Cruz; 1980; 75(3-4):33-45. PubMed ID: 6815409
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytotoxic activity of the leukocytes of chronic Chagas' disease patients against Trypanosoma cruzi].
    Olabuenaga SE; Rimoldi MT; Cardoni RL; Riera NE; Sánchez RA; Chiale P; de Bracco MM
    Medicina (B Aires); 1983; 43(2):168-74. PubMed ID: 6420643
    [No Abstract]   [Full Text] [Related]  

  • 4. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    Am J Trop Med Hyg; 1978 Nov; 27(6):1097-1107. PubMed ID: 83110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
    Powell MR; Kuhn RE
    J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens.
    Teixeira AR; Santos-Buch CA
    Immunology; 1975 Mar; 28(3):401-10. PubMed ID: 805088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies in Trypanosoma cruzi infection.
    Sánchez DO; González Cappa SM
    Medicina (B Aires); 1983; 43(1):41-6. PubMed ID: 6410148
    [No Abstract]   [Full Text] [Related]  

  • 8. Isotype of lytic antibodies in serum of Chagas' disease patients.
    Romeiro SA; Takehara HA; Mota I
    Clin Exp Immunol; 1984 Feb; 55(2):413-8. PubMed ID: 6421519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagas' disease: potential for immunoprophylaxis.
    Lancet; 1980 Mar; 1(8166):466. PubMed ID: 6102192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic studies on Trypanosoma cruzi, the causative agent of Chagas' disease].
    Ostmann H; Oelerich S; Lederer I
    Z Tropenmed Parasitol; 1973 Mar; 24(1):72-80. PubMed ID: 4200244
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serological studies in patients with chronic Chagas' disease].
    Carbonetto CH; Hajos SE; Margni RA; Esteva M; Cristopoulos C
    Medicina (B Aires); 1983; 43(2):131-6. PubMed ID: 6420641
    [No Abstract]   [Full Text] [Related]  

  • 14. Isotype of antibodies responsible for immune lysis in Trypanosoma cruzi infected mice.
    Stefani MM; Takehara HA; Mota I
    Immunol Lett; 1983; 7(2):91-7. PubMed ID: 6418640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chagas' disease: Trypanosoma cruzi vs. the host immune system. 36th forum in immunology.
    Res Immunol; 1991 Feb; 142(2):123-81. PubMed ID: 1907751
    [No Abstract]   [Full Text] [Related]  

  • 17. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: the T-cell dependence of the primary immune response and the effects of depletion of T cells and Ig-bearing cells on immunological memory.
    Burgess DE; Hanson WL
    Cell Immunol; 1980 Jun; 52(1):176-86. PubMed ID: 6771021
    [No Abstract]   [Full Text] [Related]  

  • 20. Sympathetic glial cells and macrophages develop different responses to Trypanosoma cruzi infection or lipopolysaccharide stimulation.
    de Almeida-Leite CM; Silva IC; Galvão LM; Arantes RM
    Mem Inst Oswaldo Cruz; 2014 Jul; 109(4):459-65. PubMed ID: 25075784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.